ORAL SQUAMOUS CELL CARCINOMA (OSCC)
Clinical trials for ORAL SQUAMOUS CELL CARCINOMA (OSCC) explained in plain language.
Never miss a new study
Get alerted when new ORAL SQUAMOUS CELL CARCINOMA (OSCC) trials appear
Sign up with your email to follow new studies for ORAL SQUAMOUS CELL CARCINOMA (OSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy before surgery shows promise for oral cancer
Disease control Not yet recruitingThis study tests whether giving the immunotherapy drug nivolumab before surgery can shrink tumors in people with advanced oral cancer. About 60 adults with resectable oral squamous cell carcinoma will receive nivolumab, then have surgery. Researchers will also look for biomarkers…
Matched conditions: ORAL SQUAMOUS CELL CARCINOMA (OSCC)
Phase: PHASE2 • Sponsor: Prof. Lars Olaf Cardell • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
Hydrogen water: new hope for oral cancer recovery?
Symptom relief Not yet recruitingThis study looks at whether rinsing with hydrogen water can help reduce pain, swelling, and mouth sores in people recovering from oral cancer surgery that involved rebuilding part of the mouth with a skin flap. About 36 adults will be randomly assigned to receive either hydrogen …
Matched conditions: ORAL SQUAMOUS CELL CARCINOMA (OSCC)
Phase: NA • Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC